A decreased NKG2D level in both ICU and moderate disease severity groups, and correlations found between the degranulation activity, NKG2D, and PD-1 expression levels, strongly support the idea that NKG2D loss is involved in the natural cytotoxicity failure and the exhausted state of NK cells during COVID-19. Here, KLRK1 is linked to COVID-19.